ORCHARD THERAPEUTICS NORTH AMERICA

Registrant on federal lobbying filings · filed 2025 to 2026

$0 Income reported

1 Clients represented

8 Filings counted

0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. It also reported $2,080,000 of in-house lobbying expenses, which is what a registrant files when it lobbies for itself. 2 filings on this record were restated by a later amendment and are left out of every total here. Everything on this page is grouped by the registrant's LDA id (401108947), not by name.

Clients 1

ORCHARD THERAPEUTICS NORTH AMERICA $2,080,000 8 filings

Reported by year 2 years

2026 $900,000 3 filings
2025 $1,180,000 5 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 5

HOUSE OF REPRESENTATIVES 7
SENATE 7
Food & Drug Administration (FDA) 4
Health & Human Services, Dept of (HHS) 4
Centers For Medicare and Medicaid Services (CMS) 3

Recent filings 10 total

Q3 report

ORCHARD THERAPEUTICS NORTH AMERICA

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $240,000 expenses · posted Oct 19, 2026

View → Q2 report

ORCHARD THERAPEUTICS NORTH AMERICA

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $190,000 expenses · posted Jul 17, 2026

View → Q1 amendment

ORCHARD THERAPEUTICS NORTH AMERICA

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $470,000 expenses · posted Apr 29, 2026

View → Q1 report

ORCHARD THERAPEUTICS NORTH AMERICA Amended

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $350,000 expenses · posted Apr 17, 2026

View → Q2 amendment

ORCHARD THERAPEUTICS NORTH AMERICA

2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $430,000 expenses · posted Mar 13, 2026

View → Q4 report

ORCHARD THERAPEUTICS NORTH AMERICA

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $260,000 expenses · posted Jan 20, 2026

View → Q3 report

ORCHARD THERAPEUTICS NORTH AMERICA

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $220,000 expenses · posted Oct 16, 2025

View → Registration amendment

ORCHARD THERAPEUTICS NORTH AMERICA

3rd Quarter 2025 (July 1 - Sep 30) · posted Sep 16, 2025

View → Q2 report

ORCHARD THERAPEUTICS NORTH AMERICA Amended

2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $220,000 expenses · posted Jul 17, 2025

View → Q1 report

ORCHARD THERAPEUTICS NORTH AMERICA

1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $270,000 expenses · posted Apr 18, 2025

View →

Keep going

Filings through October 19, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.